The drugs are being recalled because they may not be sterile, the company said.
The products were distributed to hospitals in New York City. Infusion Optics has notified its customers.
“Consumers that have products from Infusion Options within expiry should stop using and return to Infusion Options for destruction,” the recall notice reads.
More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.